EFICÁCIA DE UMA VACINA DE PROTEÍNA F PRÉ-FUSÃO DO VÍRUS SINCICIAL RESPIRATÓRIO (RSVPREF3 OA) EM ADULTOS MAIS VELHOS COM CONDIÇÕES CARDIORRESPIRATÓRIAS COEXISTENTES
Lessandra Michelina,
, Veronica Hulstroma, Alberto Papib, Robert G. Feldmanc, Raffaele Antonelli-Incalzid, Katie Steenackerse, Dong-Gun Leef, Michael G. Isong, Laurence Fissettea, Marie-Pierre Davida, Céline Maréchala, Lusine Kostanyana, Marie Van der Wielena
Corresponding author
a GSK
b St. Anna University Hospital, University of Ferrara, Ferrara, Itália
c Clinical Trials Inc., Little Rock, Estados Unidos
d Università Campus Bio-Medico di Roma, Roma, Itália
e University of Antwerp, Antuérpia, Bélgica
f Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Coreia do Sul
g National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Estados Unidos
Read
261
Timeswas read the article
124
Total PDF
137
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 13 | 8 | 21 |
| 2024 April | 24 | 21 | 45 |
| 2024 March | 42 | 22 | 64 |
| 2024 February | 23 | 17 | 40 |
| 2024 January | 12 | 12 | 24 |
| 2023 December | 15 | 26 | 41 |
| 2023 November | 8 | 18 | 26 |
